Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP613712.RAgrzmztQ3fFSs71W12qadBpo2WsMRM0D_04vuNT1EuN0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP613712.RAgrzmztQ3fFSs71W12qadBpo2WsMRM0D_04vuNT1EuN0130_assertion type Assertion NP613712.RAgrzmztQ3fFSs71W12qadBpo2WsMRM0D_04vuNT1EuN0130_head.
- NP613712.RAgrzmztQ3fFSs71W12qadBpo2WsMRM0D_04vuNT1EuN0130_assertion description "[We evaluate whether molecular monitoring of minimal residual disease (MRD) using TCR delta (TCRD), TCR gamma (TCRG), and immunoglobulin H (IgH) gene rearrangements in the bone marrow (BM) is correlated with clinical events in ALL patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP613712.RAgrzmztQ3fFSs71W12qadBpo2WsMRM0D_04vuNT1EuN0130_provenance.
- NP613712.RAgrzmztQ3fFSs71W12qadBpo2WsMRM0D_04vuNT1EuN0130_assertion evidence source_evidence_literature NP613712.RAgrzmztQ3fFSs71W12qadBpo2WsMRM0D_04vuNT1EuN0130_provenance.
- NP613712.RAgrzmztQ3fFSs71W12qadBpo2WsMRM0D_04vuNT1EuN0130_assertion SIO_000772 16247752 NP613712.RAgrzmztQ3fFSs71W12qadBpo2WsMRM0D_04vuNT1EuN0130_provenance.
- NP613712.RAgrzmztQ3fFSs71W12qadBpo2WsMRM0D_04vuNT1EuN0130_assertion wasDerivedFrom befree-20140225 NP613712.RAgrzmztQ3fFSs71W12qadBpo2WsMRM0D_04vuNT1EuN0130_provenance.
- NP613712.RAgrzmztQ3fFSs71W12qadBpo2WsMRM0D_04vuNT1EuN0130_assertion wasGeneratedBy ECO_0000203 NP613712.RAgrzmztQ3fFSs71W12qadBpo2WsMRM0D_04vuNT1EuN0130_provenance.